{
    "2019-02-28": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Aduro (ADRO) Q4 Earnings and Revenues Fall Shy of Estimates",
                "features": {
                    "keywords": [
                        "Aduro",
                        "Q4",
                        "Earnings",
                        "Revenues",
                        "Fall",
                        "Estimates"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Momenta Continues to Rebuild",
                "features": {
                    "keywords": [
                        "Momenta",
                        "Rebuild"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Novartis faces shareholder criticism over drug prices at AGM",
                "features": {
                    "keywords": [
                        "Novartis",
                        "shareholder",
                        "criticism",
                        "drug",
                        "prices",
                        "AGM"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Ionis Pharmaceuticals (IONS) Q4 2018 Earnings Conference Call Transcript",
                "features": {
                    "keywords": [
                        "Ionis",
                        "Pharmaceuticals",
                        "Q4",
                        "2018",
                        "Earnings",
                        "Conference",
                        "Call",
                        "Transcript"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}